2023 annual financial data

Agios Pharmaceuticals 2023 Operating margin

Agios Pharmaceuticals 2023 operating margin with verified reported values.

Direct answer

Operating margin was -1,459.52%.

Operating income was -391,487,000 USD and net income was -352,088,000 USD.
Operating cash flow was -296,062,000 USD.

Get free Agios Pharmaceuticals email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
26,823,000 USD
Operating income
-391,487,000 USD
Net income
-352,088,000 USD
Operating cash flow
-296,062,000 USD